Dimol antacid

Brand Overview and Origin

Dimol is a well-established pharmaceutical brand specializing in antacid and anti-flatulence treatments. Its primary function is to relieve symptoms such as heartburn, indigestion, and gas. The brand was developed in Israel to serve the local healthcare market, providing an effective solution for gastrointestinal discomfort.

Manufacturing and Brand Ownership

Dimol is manufactured and owned by Dexcel Pharma (formerly known as Dexxon). Dexcel Pharma is Israel's largest privately owned pharmaceutical company, with its headquarters and primary manufacturing facilities located within the country. While Dexcel has a significant global presence, including operations in the UK, Germany, and the United States, Dimol remains a key product within its domestic Israeli portfolio. The company maintains rigorous quality standards, ensuring that the manufacturing process adheres to international pharmaceutical regulations.